← Back to all trials
Active Not Recruiting
NCT05038852
Acceptability of Mobile Applications (Apps) to Enhance Smoking Cessation in a Clinical Tobacco Treatment Program - A Pilot Study
Conditions: Smoking Cessation, Tobacco
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 8
Sponsor: M.D. Anderson Cancer Center
Location: M D Anderson Cancer Center Houston Texas
Summary
We will conduct a small-scale randomized controlled trial (RCT) with 24 adult smokers enrolled in the TTP. Participants will receive either the Free4Good mobile app for positive psychology skills training or a breathing relaxation mobile app control (Breathe2Relax). All participants will be receiving tobacco cessation treatment in the Tobacco Treatment Program at MD Anderson as standard of care.
Eligibility Criteria
Inclusion criteria:
* MD Anderson patient between the ages of 18 to 65
* current smoker (i.e., at least 1 cigarette or e-cig per day)
* smoking for at least one year,
* willing to set a quit date in the next 30 days,
* not engaged in smoking cessation treatment other than the MDACC Tobacco Treatment Program
* English speaking and ability to read and comprehend English, and 7) currently own an iOS mobile phone (iPhone) using iOS 9.0 or later and reports regular use (at least weekly) of at least 1 iOS app.
Exclusion Criteria
* endorsing current suicidal ideation or intent,
* meeting criteria for a current Major Depressive Episode measured by the PHQ-9,
* any medical or psychiatric condition, illness, disorder, or concomitant medication that could compromise participant safety or treatment, as determined by the Principal Investigator or Collaborator,
* subject considered by the investigator an unsuitable candidate for receipt of a smoking cessation treatment or unstable to be followed up throughout the entire duration of the study.
* Pregnant women will not be excluded from participating in the study and any decisions about potential pharmacotherapy will be done as standard of care in the Tobacco Treatment Program, including a consultation with the medical team and a joint decision-making process with the patient to determine the best course of treatment given all co-morbid medical conditions.
Source: ClinicalTrials.gov (NCT05038852). StuddyBuddy aggregates publicly available trial information.